NIH-funded project aims to take NSAIDs beyond the 'art of medicine'
20:35 EDT 20 Aug 2012 | SCRIP
Hindsight is always 20/20. Or is it? Even eight years after Merck withdrew Vioxx (rofecoxib) from the worldwide market and seven years since the US FDA asked makers of all prescription nonsteroidal anti-inflammatory drugs (NSAIDs) to.....
Original Article: NIH-funded project aims to take NSAIDs beyond the 'art of medicine'
More From BioPortfolio on "NIH-funded project aims to take NSAIDs beyond the 'art of medicine'"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
